West Pharmaceutical Services (WST) net income: $494M
West Pharmaceutical Services reported a net income of $494M for the year ended Dec 31, 2025, up 0.2% from $493M a year earlier.
From West Pharmaceutical Services's filings with the SEC · Read the filing · WST stock page
West Pharmaceutical Services net income by year
#592 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $494M | +0% |
| Dec 31, 2024 | $493M | -17% |
| Dec 31, 2023 | $593M | +1% |
| Dec 31, 2022 | $586M | -11% |
| Dec 31, 2021 | $662M | – |
Net income of similar companies
Companies in the same industry as West Pharmaceutical Services, by SEC industry code, with the closest net income. Each name opens the same page for that company.
Questions and answers
What is West Pharmaceutical Services's net income?
West Pharmaceutical Services reported a net income of $494M for the year ended Dec 31, 2025, up 0.2% from $493M a year earlier.
Numbers as reported in West Pharmaceutical Services's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology